InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
79,675.85
(
3.78%
)
Post# of 1048
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Pink Current

Send PM Follow Ignore
Followers 270
Posts 12274
Boards Moderated 0
Alias Born 04/05/2007

Pink Current

Re: TheKobra post# 942

Thursday, 01/07/2016 8:32:44 AM

Thursday, January 07, 2016 8:32:44 AM

Post# of 1048
Looking good for today.....from latest 8K

Exhibit 99.1 is a press release issued by Eiger on January 6, 2016 entitled “Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 LOWR HDV – 4 (LOnafarnib With Ritonavir in Hepatitis Delta Virus – 4) Study at Hannover Medical School in Hannover, Germany.”



http://ih.advfn.com/p.php?pid=nmona&article=69912725&symbol=CLDN

Moving right along to human trials now.

CLDN

HPT

Disclaimer: The views expressed by me are solely those of the author and should not be construed as reason to buy or sell any security I mention. Always do your own DD(due diligence), I have.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up